Literature DB >> 18785456

Genetic admixture: a tool to identify diabetic nephropathy genes in African Americans.

Jasmin Divers1, Shahriar Moossavi, Carl D Langefeld, Barry I Freedman.   

Abstract

Diseases with an inherited component that demonstrate different prevalence in various ancestral populations can now be studied using admixture mapping in an appropriate admixed population. This strategy called mapping by admixture linkage disequilibrium or MALD utilizes polymorphic genetic markers that are spaced throughout the genome to identify genomic regions where the estimated admixture proportion is significantly different than its expected value. These genetic markers are selected based on their ancestry informativeness content. The MALD approach assumes that genomic regions showing excess ancestry from the ancestral population with higher disease prevalence, in the sample of admixed individuals, are more likely to harbor polymorphisms that confer higher risk to disease than others. Certain conditions including essential hypertension, type 2 diabetes mellitus and common complex forms of nephropathy demonstrate clear differences in disease frequency in individuals of African and European descent and appear particularly suited to this type of analysis. Genetic admixture can also cause confounding in association studies conducted on an admixed sample leading to inflated type I error rates and possible loss of power. This manuscript describes the background, methodologies and uses for admixture mapping in the search for genes that underlie type 2 diabetes mellitus and its associated nephropathy in the African American population, and statistical methods to address the confounding issues in genetic association tests.

Entities:  

Mesh:

Year:  2008        PMID: 18785456

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  7 in total

1.  Genetic ancestry in lung-function predictions.

Authors:  Rajesh Kumar; Max A Seibold; Melinda C Aldrich; L Keoki Williams; Alex P Reiner; Laura Colangelo; Joshua Galanter; Christopher Gignoux; Donglei Hu; Saunak Sen; Shweta Choudhry; Edward L Peterson; Jose Rodriguez-Santana; William Rodriguez-Cintron; Michael A Nalls; Tennille S Leak; Ellen O'Meara; Bernd Meibohm; Stephen B Kritchevsky; Rongling Li; Tamara B Harris; Deborah A Nickerson; Myriam Fornage; Paul Enright; Elad Ziv; Lewis J Smith; Kiang Liu; Esteban González Burchard
Journal:  N Engl J Med       Date:  2010-07-07       Impact factor: 91.245

Review 2.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 3.  Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation.

Authors:  Cheryl A Winkler; George Nelson; Taras K Oleksyk; M Berenice Nava; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 4.  Effect of race and genetics on vitamin D metabolism, bone and vascular health.

Authors:  Barry I Freedman; Thomas C Register
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

5.  Genetic admixture is associated with plasma hemostatic factor levels in self-identified African Americans and Hispanics: the Multi-Ethnic Study of Atherosclerosis.

Authors:  P L Lutsey; C L Wassel; M Cushman; M M Sale; J Divers; A R Folsom
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

Review 6.  Red blood cell alloimmunization in sickle cell disease: listen to your ancestors.

Authors:  Sally A Campbell-Lee; Rick A Kittles
Journal:  Transfus Med Hemother       Date:  2014-11-14       Impact factor: 3.747

Review 7.  Reappraisal of the impact of race on survival in patients on dialysis.

Authors:  Vardaman M Buckalew; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2010-06       Impact factor: 8.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.